Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Motor Improvement in Early Parkinson Disease under Treatment with Safinamide a New Neuroprotectant. Results from a Parallel Double Blind Placebo Controlled Multinational Study
094
Authors/Disclosures
Hadi M. Mohammad Khanli, MD (City of Hope National Cancer Center) Dr. Mohammad Khanli has nothing to disclose.
David H. Margolin, MD, PhD (Genzyme Corporation) Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
No disclosure on file
Madalina Chirieac, MD No disclosure on file
No disclosure on file
No disclosure on file
Xiaodong Luo (Sanofi) Xiaodong Luo has received personal compensation for serving as an employee of Sanofi. An immediate family member of Xiaodong Luo has received personal compensation for serving as an employee of Beigene. Xiaodong Luo has stock in Sanofi. An immediate family member of Xiaodong Luo has stock in Beigene. An immediate family member of Xiaodong Luo has stock in Johnson and Johnson.
No disclosure on file
No disclosure on file
No disclosure on file